Electra Therapeutics Inc.
3 clinical trials · Sponsor
◉ Watch Electra Therapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs) (NCT07465835) | Electra Therapeutics Inc. | 2026-02-17 |
| Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH) (NCT05416307) | Electra Therapeutics Inc. | 2022-05-19 |
| Evaluation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ELA026 in Single and Multiple Doses in Healthy Volunteers (NCT05556863) | Electra Therapeutics Inc. | 2021-10-18 |
Track Electra Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.